Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001493152-21-009799
Filing Date
2021-04-26
Accepted
2021-04-26 21:52:43
Documents
5
Effectiveness Date
2021-04-26

Document Format Files

Seq Description Document Type Size
1 forms-1mef.htm S-1MEF 79463
2 ex5-1.htm EX-5.1 33367
3 ex23-1.htm EX-23.1 4620
4 image_001.jpg GRAPHIC 4892
5 image_002.jpg GRAPHIC 3784
  Complete submission text file 0001493152-21-009799.txt   130959
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-255525 | Film No.: 21855696
SIC: 7389 Services-Business Services, NEC